Summit Trail Advisors, LLC Biogen Inc. Transaction History

Summit Trail Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	BUY	$264.77 - $305.71 $1.62 Million - $1.87 Million	6,107 New	6,107 $1.16 Million
Q1 2019 May 16, 2019	SELL	$216.71 - $338.96 $328,965 - $514,541	-1,518 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$278.5 - $352.75 $371,797 - $470,921	-1,335 Reduced 46.79%	1,518 $457,000
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $71,322 - $93,270	243 Added 9.31%	2,853 $1.01 Million
Q2 2018 Aug 10, 2018	SELL	$257.52 - $306.91 $1.33 Million - $1.59 Million	-5,169 Reduced 66.45%	2,610 $757,000
Q1 2018 May 22, 2018	SELL	$260.13 - $367.91 $386 Million - $546 Million	-1,483,309 Reduced 99.48%	7,779 $1.49 Million
Q1 2018 May 21, 2018	BUY	$260.13 - $367.91 $386 Million - $546 Million	1,485,089 Added 24755.61%	1,491,088 $1.49 Million
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $1.85 Million - $2.07 Million	5,999	5,999 $2.04 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Summit Trail Advisors, LLC with notifications on news.